Found 14 matching trials
Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma PHASE2 The purpose of this study is to determine if neoadjuvant (treatment before ...
Show More Location
Moffitt Cancer Center
Learn More & Join Trial
Saci Nivo Rela for TNBC PHASE1 This is a randomized, open-label, phase Ib study to assess safety and effic...
Show More Learn More & Join Trial
Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma PHASE2 The goal of this clinical trial is to test neoadjuvant dual immunotherapy i...
Show More Location
Melanoma Institute Australia
Learn More & Join Trial
A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable Melanoma PHASE3 The purpose of this study is to demonstrate that the study drug exposure le...
Show More Status
Active Not Recruiting
Location
Local Institution - 0125
Learn More & Join Trial
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head) PHASE3 This study is researching an experimental drug called fianlimab (also known...
Show More Location
Ironwood Cancer & Research Centers
Learn More & Join Trial
A Phase 2 Clinical Trial of Neoadjuvant Relatlimab and Nivolumab in High Risk, Clinical Stage II Cutaneous Melanoma PHASE2 Neoadjuvant therapy is feasible in stage II melanoma, and the dual inhibiti...
Show More Status
Active Not Recruiting
Location
Melanoma Institute Australia
Learn More & Join Trial
A Study of IO102/IO103, Nivolumab, and Relatlimab in People With Melanoma PHASE2 The researchers are doing this study to find out whether the study vaccines...
Show More Status
Active Not Recruiting
Location
Hartford Healthcare Alliance (Data Collection Only)
Learn More & Join Trial
Expanded Access for Fixed-Dose Combination of Nivolumab Plus Relatlimab N/A This is an expanded access designed to provide access to fixed-dose combina...
Show More Status
No Longer Available
Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations PHASE2 The purpose of this study is to assess the patient's preference for nivolum...
Show More Status
Active Not Recruiting
Location
Local Institution - 0007
Learn More & Join Trial
Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis PHASE1 This study is being done to see if combining HEPZATO KIT™ with nivolumab an...
Show More Location
UW Hospital and Clinics
Learn More & Join Trial